On the evening of August 27, Yaoyigou disclosed that its chairman and general manager, Chen Shunjun, resigned from his posts as chairman, director, general manager, chairman of the strategy and development committee, and member of the remuneration and assessment committee, after omitting related-party information provided to the company and its auditors. Chen's original term was set to run from July 30, 2025, until the end of the fourth board of directors' term. After resigning, he no longer holds other senior management positions, but remains at the company focusing on innovative growth-side business. Yaoyigou is the first listed pharmaceutical industry internet company in China. In 2025, it recorded its first annual loss since listing, with net profit attributable to the parent company of minus 12.85 million yuan. In the first half of 2026, the loss widened year-on-year to minus 9.527 million yuan. In the secondary market, the company's share price has been volatile this year, closing at 25.22 yuan per share on August 27.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.Chairman resigns over omission of related-party information, a governance/regulatory issue.
